Page last updated: 2024-11-08

biguanides and Non-alcoholic Fatty Liver Disease

biguanides has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research Excerpts

ExcerptRelevanceReference
" A multivariate analysis with multiple logistic regression revealed that visceral fat accumulation was inhibited in women and those taking statins or thiazolidines and aggravated in men and those with obesity or an increased waist circumference."3.80Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes. ( Ichikawa, T; Kohno, S; Nakao, K; Onitsuka, Y; Takeshima, F, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Onitsuka, Y1
Takeshima, F1
Ichikawa, T1
Kohno, S1
Nakao, K1

Other Studies

1 other study available for biguanides and Non-alcoholic Fatty Liver Disease

ArticleYear
Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:6

    Topics: Aged; Biguanides; Body Composition; Body Mass Index; Diabetes Mellitus, Type 2; Diet, Western; Femal

2014